Healthcare provider profile · identity verified

Joseph A. Picca, MD

Family Practice · HONEOYE FALLS, NY · NPI 1245378215

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	521	150
Lisinopril	Lisinopril	407	110
Amlodipine Besylate	Amlodipine Besylate	396	114
Losartan Potassium	Losartan Potassium	348	93
Levothyroxine Sodium	Levothyroxine Sodium	315	87
Metoprolol Succinate	Metoprolol Succinate	297	85
Omeprazole	Omeprazole	265	81
Tamsulosin Hcl	Tamsulosin Hcl	244	66
Gabapentin	Gabapentin	234	62
Hydrochlorothiazide	Hydrochlorothiazide	197	58
Rosuvastatin Calcium	Rosuvastatin Calcium	197	65
Simvastatin	Simvastatin	196	57
Metformin Hcl	Metformin Hcl	194	52
Pantoprazole Sodium	Pantoprazole Sodium	154	47
Trazodone Hcl	Trazodone Hcl	141	32
Metformin Hcl Er	Metformin Hcl	134	34
Allopurinol	Allopurinol	122	34
Albuterol Sulfate Hfa	Albuterol Sulfate	105	42
Fluoxetine Hcl	Fluoxetine Hcl	104	23
Pioglitazone Hcl	Pioglitazone Hcl	103	26
Chlorthalidone	Chlorthalidone	101	24
Spironolactone	Spironolactone	100	23
Eliquis	Apixaban	95	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	93	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	20
Zolpidem Tartrate	Zolpidem Tartrate	88	20
Finasteride	Finasteride	85	21
Prednisone	Prednisone	85	44
Famotidine	Famotidine	84	27
Sertraline Hcl	Sertraline Hcl	84	23
Meloxicam	Meloxicam	83	24
Alprazolam	Alprazolam	81	25
Jardiance	Empagliflozin	80	17
Torsemide	Torsemide	80	21
Pravastatin Sodium	Pravastatin Sodium	78	27
Hydroxyzine Hcl	Hydroxyzine Hcl	77	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	21
Potassium Chloride	Potassium Chloride	75	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	16
Oxycodone Hcl	Oxycodone Hcl	68	13
Atenolol	Atenolol	65	19
Tramadol Hcl	Tramadol Hcl	65	20
Glipizide	Glipizide	63	16
Metoprolol Tartrate	Metoprolol Tartrate	63	22
Escitalopram Oxalate	Escitalopram Oxalate	62	16
Pregabalin	Pregabalin	62	15
Furosemide	Furosemide	60	18
Celecoxib	Celecoxib	59	17
Duloxetine Hcl	Duloxetine Hcl	58	20
Alendronate Sodium	Alendronate Sodium	56	13
Clopidogrel	Clopidogrel Bisulfate	56	16
Warfarin Sodium	Warfarin Sodium	56	13
Venlafaxine Hcl Er	Venlafaxine Hcl	54	11
Fluticasone Propionate	Fluticasone Propionate	53	21
Arexvy	Rsvpref3 Antigen/As01e/Pf	51	51
Bupropion Xl	Bupropion Hcl	51	13
Oxybutynin Chloride Er	Oxybutynin Chloride	50	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	15
Carvedilol	Carvedilol	48	12
Clonazepam	Clonazepam	45	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	45	42
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	suppressed
Terazosin Hcl	Terazosin Hcl	43	12
Mounjaro	Tirzepatide	41	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Lorazepam	Lorazepam	38	12
Ketoconazole	Ketoconazole	37	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Lovastatin	Lovastatin	37	12
Montelukast Sodium	Montelukast Sodium	37	13
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	36	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	36	25
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	13
Triamcinolone Acetonide	Triamcinolone Acetonide	34	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Fosinopril Sodium	Fosinopril Sodium	32	suppressed
Mirtazapine	Mirtazapine	32	12
Ozempic	Semaglutide	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Valsartan	Valsartan	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	16
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Colchicine	Colchicine	23	11
Baclofen	Baclofen	22	suppressed
Diazepam	Diazepam	22	12
Ondansetron Hcl	Ondansetron Hcl	22	14
Testosterone	Testosterone	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Rybelsus	Semaglutide	20	suppressed
Cephalexin	Cephalexin	19	17
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Digoxin	Digoxin	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	17	17
Carbamazepine	Carbamazepine	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Metolazone	Metolazone	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	15	suppressed
Ramipril	Ramipril	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Benazepril Hcl	Benazepril Hcl	14	suppressed
Cefdinir	Cefdinir	14	14
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Ezetimibe	Ezetimibe	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Carvedilol Er	Carvedilol Phosphate	11	suppressed
Constulose	Lactulose	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Indomethacin Er	Indomethacin	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Mresvia	Rsv Vaccine, Pref, Mrna/Pf	11	11
Mupirocin	Mupirocin	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error